Intervenient Treatment of Uterine Malinancy and Uterine Hemorrhage<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />

范海伦　贺能树

天津医科大学总医院放射科，天津 300052

Hai-lun Fan, Neng-shu He

Deper-tment of Radiology, Tianjing medical university general hospital, Tianjin 300052

ABSTRACT

Objective：To evaluate the clinical outcomes of chemotherapeutic infusion and embolism by superselective uterine artery catherterization for treatment of uterine malignancy and uterine hemorrhage.

Methods：Chemotherapeutic infusion and embolism by superselective uterine artery catherterization was perfomed on 55 patients with uterine malignancy and 7 patients with uterine hemorrhage.

Result：Angiographic success was obtained in all patients after chemotherapeutic infusion and embolism by superselective uterine artery catherterization treatment.

Conclusions：Treatment uterine malignancy and uterine hemorrhage using chemotherapeutic infusion and embolism by superslective uterine artery catherterization could obtain better clinical outcomes.

Key words：Uterine malignancy; Intervenient; Treatment

在我国子宫肿瘤是威胁妇女生命的主要疾病之一，手术和(或)放疗是主要的治疗手段。产后子宫大出血是产科常见的严重并发症,是产妇死亡的主要原因，而且死亡率由1992年的33.3%上升至1994年的49.9%^[1]。以往这类病人一般临床上多采用子宫切除术来挽救患者生命。近年来，笔者在子宫肿瘤根治术前或失去手术机会的晚期病例行超选择子宫动脉灌注化疗，对产后子宫大出血患者采用双侧子宫动脉栓塞术治疗，均取得较好疗效。

临床资料与方法

1999年4月～2004年12月采用超选择子宫动脉栓塞化疗治疗子宫恶性肿瘤55例,其中子宫内膜癌18例,宫颈癌29例,子宫恶性葡萄胎8例。采用超选择子宫动脉栓塞术治疗产后子宫大出血7例，宫颈异位妊娠大出血2例。年龄21～76岁,平均42.51±17.38岁。